Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Clark

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
Nature Communications|January 12, 2021
BRD4-mediated repression of p53 is a target for combination therapy in AMLAnne-Louise Latif, Ashley Newcombe, Sha Li, et al.
The Journal of Urology|October 24, 2025
Reply by AuthorsSam S Chang, Karim Chamie, Eugene Kramolowsky, et al.
The New England Journal of Medicine|June 21, 2023
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease ProphylaxisJavier Bolaños-Meade, Mehdi Hamadani, Juan Wu, et al.
Nature Communications|June 9, 2021
Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesisJoshua D G Leach, Nikola Vlahov, Petros Tsantoulis, et al.
Science Translational Medicine|August 17, 2018
TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescenceThomas G Bird, Miryam Müller, Luke Boulter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2025
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, et al.
Nature|June 3, 2021
NOTUM from Apc-mutant cells biases clonal competition to initiate cancerDustin J Flanagan, Nalle Pentinmikko, Kalle Luopajärvi, et al.
Nature Cell Biology|November 13, 2024
Hepatocellular senescence induces multi-organ senescence and dysfunction via TGFβChristos Kiourtis, Maria Terradas-Terradas, Lucy M Gee, et al.
Nature Communications|December 8, 2022
Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive featuresDustin J Flanagan, Raheleh Amirkhah, David F Vincent, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 studyJakob Wirbel, Wael Saber, Michael J Martens, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
Nature Communications|January 12, 2021
BRD4-mediated repression of p53 is a target for combination therapy in AMLAnne-Louise Latif, Ashley Newcombe, Sha Li, et al.
The Journal of Urology|October 24, 2025
Reply by AuthorsSam S Chang, Karim Chamie, Eugene Kramolowsky, et al.
The New England Journal of Medicine|June 21, 2023
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease ProphylaxisJavier Bolaños-Meade, Mehdi Hamadani, Juan Wu, et al.
Nature Communications|June 9, 2021
Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesisJoshua D G Leach, Nikola Vlahov, Petros Tsantoulis, et al.
Science Translational Medicine|August 17, 2018
TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescenceThomas G Bird, Miryam Müller, Luke Boulter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2025
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, et al.
Nature|June 3, 2021
NOTUM from Apc-mutant cells biases clonal competition to initiate cancerDustin J Flanagan, Nalle Pentinmikko, Kalle Luopajärvi, et al.
Nature Cell Biology|November 13, 2024
Hepatocellular senescence induces multi-organ senescence and dysfunction via TGFβChristos Kiourtis, Maria Terradas-Terradas, Lucy M Gee, et al.
Nature Communications|December 8, 2022
Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive featuresDustin J Flanagan, Raheleh Amirkhah, David F Vincent, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 studyJakob Wirbel, Wael Saber, Michael J Martens, et al.
Pageof 16